Deutsch English Français

Contact

EP2844224

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2844224

EP2844224 - DRUG DELIVERY SYSTEM FOR TREATING OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION [Right-click to bookmark this link]
Former [2015/11]	DRUG DELIVERY SYSTEM AND METHODS OF TREATING OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
	[2017/09]
Status	No opposition filed within time limit Status updated on 15.02.2019 Database last updated on 13.07.2024
Former	The patent has been granted Status updated on 09.03.2018
Former	Grant of patent is intended Status updated on 06.09.2017
Former	Examination is in progress Status updated on 16.06.2017
Former	Grant of patent is intended Status updated on 07.02.2017
Former	Examination is in progress Status updated on 01.11.2016
Most recent event Tooltip	01.07.2022	Lapse of the patent in a contracting state New state(s): MK	published on 03.08.2022 [2022/31]
Applicant(s)	For all designated states Mati Therapeutics Inc. 4317 Dunning Lane Austin, TX 78746 / US
	For all designated states Utkhede, Deepank 18263 68th Avenue Surrey, BC V3S 9C6 / CA
	For all designated states Cadden, Suzanne 1800 Rogers Road No 301 Fort Worth TX 76107 / US
	For all designated states Hao, Yong 6820 Fleming Street Vancouver, BC V5P 3H5 / CA
	[2017/40]
Former [2015/23]	For all designated states Mati Therapeutics Inc. 4317 Dunning Lane Austin, TX 78746 / US
	For all designated states Utkhede, Deepank 18263 68th Avenue Surrey, BC V3S 9C6 / CA
	For all designated states Cadden, Suzanne 5829 Grousewoods Crescent North Vancover, BC V7R 4V3 / CA
	For all designated states Hao, Yong 6820 Fleming Street Vancouver, BC V5P 3H5 / CA
Former [2015/11]	For all designated states QLT Inc. 887 Great Northern Way Suite 101 Vancouver, BC V5T 4T5 / CA
	For all designated states Utkhede, Deepank 18263 68th Avenue Surrey, BC V3S 9C6 / CA
	For all designated states Cadden, Suzanne 5829 Grousewoods Crescent North Vancover, BC V7R 4V3 / CA
	For all designated states Hao, Yong 6820 Fleming Street Vancouver, BC V5P 3H5 / CA
Inventor(s)	01 / UTKHEDE, Deepank 18263 68th Avenue Surrey, BC V3S 9C6 / CA
	02 / CADDEN, Suzanne 1800 Rogers Road No. 301 Fort Worth, TX 76107 / CA
	03 / HAO, Yong 6820 Fleming Street Vancouver, BC V5P 3H5 / CA
	[2015/43]
Former [2015/36]	01 / UTKHEDE, Deepank 18263 68th Avenue Surrey, BC V3S 9C6 / CA
	02 / CADDEN, Suzanne 1800 Rogers Road No.: 301 Fort Worth, TX 76107 / CA
	03 / HAO, Yong 6820 Fleming Street Vancouver, BC V5P 3H5 / CA
Former [2015/11]	01 / UTKHEDE, Deepank 18263 68th Avenue Surrey, BC V3S 9C6 / CA
	02 / CADDEN, Suzanne 5829 Grousewoods Crescent North Vancover, BC V7R 4V3 / CA
	03 / HAO, Yong 6820 Fleming Street Vancouver, BC V5P 3H5 / CA
Representative(s)	HGF 1 City Walk Leeds LS11 9DX / GB
	[N/P]
Former [2018/15]	HGF Limited 1 City Walk Leeds LS11 9DX / GB
Former [2015/11]	HGF Limited Belgrave Hall Belgrave Street Leeds LS2 8DD / GB
Application number, filing date	13784720.8	27.02.2013
	[2018/15]
	WO2013IB00694
Priority number, date	US201261642287P	03.05.2012 Original published format: US 201261642287 P
	US201261644401P	08.05.2012 Original published format: US 201261644401 P
	US201261644397P	08.05.2012 Original published format: US 201261644397 P
	US201261659921P	14.06.2012 Original published format: US 201261659921 P
	US201261680641P	07.08.2012 Original published format: US 201261680641 P
	US201261717615P	23.10.2012 Original published format: US 201261717615 P
	[2015/11]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013164671
	Date:	07.11.2013
	Language:	EN
	[2013/45]
	Type:	A1 Application with search report
	No.:	EP2844224
	Date:	11.03.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.11.2013 takes the place of the publication of the European patent application.
	[2015/11]
	Type:	B1 Patent specification
	No.:	EP2844224
	Date:	11.04.2018
	Language:	EN
	[2018/15]
Search report(s)	International search report - published on:	CA	07.11.2013
	(Supplementary) European search report - dispatched on:	EP	22.01.2016
Classification	IPC:	A61K9/00, A61F2/02, A61K31/5575, A61L31/06, A61L31/16, A61M31/00, A61F9/00	[2016/08]
	CPC:	A61F9/00781 (EP); A61K31/5575 (EP); A61K9/0051 (EP); A61P27/02 (EP); A61P27/06 (EP); A61K9/7007 (EP)
	Former IPC [2015/11]	A61K9/00, A61F9/00, A61K31/5575, A61L31/04, A61L31/16, A61P27/06
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/11]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	WIRKSTOFFFREISETZUNGSSYSTEM FÜR BEHANDLUNG VON OFFENWINKELGLAUKOM UND OKULARER HYPERTONIE	[2017/09]
	English:	DRUG DELIVERY SYSTEM FOR TREATING OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION	[2017/09]
	French:	SYSTÈME D'ADMINISTRATION DE MÉDICAMENT POUR LE TRAITEMENT D'UN GLAUCOME À ANGLE OUVERT ET DE L'HYPERTENSION OCULAIRE	[2017/09]
	Former [2015/11]	WIRKSTOFFFREISETZUNGSSYSTEM UND VERFAHREN ZUR BEHANDLUNG VON OFFENWINKELGLAUKOM UND OKULARER HYPERTONIE
	Former [2015/11]	DRUG DELIVERY SYSTEM AND METHODS OF TREATING OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
	Former [2015/11]	SYSTÈME D'ADMINISTRATION DE MÉDICAMENT ET PROCÉDÉS DE TRAITEMENT D'UN GLAUCOME À ANGLE OUVERT ET DE L'HYPERTENSION OCULAIRE
Entry into regional phase	02.12.2014	National basic fee paid
	02.12.2014	Search fee paid
	02.12.2014	Designation fee(s) paid
	02.12.2014	Examination fee paid
Examination procedure	02.12.2014	Examination requested [2015/11]
	06.09.2016	Amendment by applicant (claims and/or description)
	20.10.2016	Despatch of a communication from the examining division (Time limit: M03)
	19.12.2016	Reply to a communication from the examining division
	08.02.2017	Communication of intention to grant the patent
	07.06.2017	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	07.09.2017	Communication of intention to grant the patent
	08.01.2018	Fee for grant paid
	08.01.2018	Fee for publishing/printing paid
	08.01.2018	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.10.2016
Opposition(s)	14.01.2019	No opposition filed within time limit [2019/12]
Fees paid	Renewal fee
	27.03.2015	Renewal fee patent year 03
	26.02.2016	Renewal fee patent year 04
	27.02.2017	Renewal fee patent year 05
	27.02.2018	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	27.03.2015	03 M02 Fee paid on 27.03.2015
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	27.02.2013
	AL	11.04.2018
	AT	11.04.2018
	CY	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	MK	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	TR	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	IS	11.08.2018
	PT	13.08.2018
	[2022/31]
Former [2021/32]	HU	27.02.2013
	AL	11.04.2018
	AT	11.04.2018
	CY	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	TR	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	IS	11.08.2018
	PT	13.08.2018
Former [2021/31]	AL	11.04.2018
	AT	11.04.2018
	CY	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	TR	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	IS	11.08.2018
	PT	13.08.2018
Former [2021/26]	AL	11.04.2018
	AT	11.04.2018
	CY	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	TR	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2020/16]	AL	11.04.2018
	AT	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	TR	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/45]	AL	11.04.2018
	AT	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/26]	AL	11.04.2018
	AT	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SI	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/11]	AL	11.04.2018
	AT	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	IT	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/10]	AL	11.04.2018
	AT	11.04.2018
	CZ	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RO	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	SK	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/09]	AL	11.04.2018
	DK	11.04.2018
	EE	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/08]	AL	11.04.2018
	DK	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/03]	AL	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2018/52]	AL	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
Former [2018/51]	AL	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	RS	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
Former [2018/50]	AL	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
Former [2018/49]	AL	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	LT	11.04.2018
	NL	11.04.2018
	PL	11.04.2018
	SE	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
Former [2018/47]	AL	11.04.2018
	ES	11.04.2018
	FI	11.04.2018
	LT	11.04.2018
	NL	11.04.2018
	NO	11.07.2018
Former [2018/46]	AL	11.04.2018
	LT	11.04.2018
	NL	11.04.2018
	NO	11.07.2018
Former [2018/43]	NL	11.04.2018
Documents cited:	Search	[A]US2005232972 (ODRICH STEVEN [US]) [A] 1-14* paragraphs [0014] , [0 18]; figure 2 *;
		[A]WO2008083118 (QLT PLUG DELIVERY INC [US], et al) [A] 1-14 * paragraphs [0112] - [0114]; figure 9 *;
		[IY]WO2010085696 (QLT PLUG DELIVERY INC [US], et al) [I] 1-4,9-14 * page 91, line 5 - line 18 * * page 96, line 8 - line 30 * [Y] 5-8;
		[Y]WO2010096822 (QLT PLUG DELIVERY INC [US], et al) [Y] 5-8 * paragraphs [0113] , [ 116]; figures 10A, 10B *
	International search	[X]WO2010085696 (QLT PLUG DELIVERY INC [US], et al)
	by applicant	US4281654
		US4952581
		US5296504
		US5811443
		US2002055701
		US2004170685
		US2005048121
		US2005129731
		WO2006014434
		WO2007115261
		WO2007115259
		US2008181930
		US2009099626
		US2009104248
		US2009105749
		US2009104243
		US2009280158
		WO2010085696
		US2010209477
		US2010274204
		US7910767
		WO2011066479
		- BITO, L. Z., Biological Protection with Prostaglandins, CRC PRESS INC, (1985), pages 231 - 252
		- BITO, L. Z., Applied Pharmacology in the Medical Treatment of Glaucomas Drance, GRUNE & STRATTON, (1984), pages 477 - 505
		- WINFIELD AJ ET AL., "A study of the causes of non-compliance by patients prescribed eyedrops.", BR J OPHTHALMOL., (199008), vol. 74, no. 8, pages 477 - 80
		- NORELL SE; GRANSTROM PA., "Self-medication with pilocarpine among outpatients in a glaucoma clinic", BR J OPHTHALMOL., (198002), vol. 64, no. 2, pages 137 - 41
		- ZIAI ET AL., "The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 a analogue, after topical application in normal and ocular hypertensive human eyes", ARCH OPHTHALMOL., (1993), vol. 111, pages 1351 - 1358, XP000973095
		- REALINI ET AL., "The uniocular drug trial and second-eye response to glaucoma medications", OPHTHALMOL, (2004), vol. 111, pages 421 - 426
		- LINDEN; AIM, "the effect on intraocular pressure of latanoprost once or four times daily", BR. J. OPHTHALMOL, (2001), vol. 85, pages 1163 - 1166
		US20080066223
		US20090521543
		US20040825047
		US20060571147
		US20060871867
		US20070695537
		US20070695545
		US20070970696
		US20070970699
		US20070970709
		US20070970720
		US20070970755
		US20070970820
		US20070974367
		US20080033211
		US20080036816
		US20080049347
		US20080049360
		US20080052595
		US20080075309
		US20080283002
		US20080231986
		US20080231987
		US20080231989
		US20080332219
		US20090378710
		US20090154693
		US20090209036
		US20090209630
		US20090432553
		US20090463279
		US20090490923
		US20090499605
		US20090271862
		US20090252057
	US20090604202
	US20090643502
	US20100692452
	US20100710855

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p